Merck Stock News

KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MERCK--FDA Approves Mercks KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery

Industry Insights A report titled, Global Pet Insect Repellent Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of the Pet

Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used

For a drugmaker licensed to produce Merck & Co.s promising COVID-19 pill and sell Russias Sputnik V shot, Dr Reddys Laboratories Ltd. is surprisingly mellow about the rewards it expects from these

FBI/CDC Launch Probe After "Questionable Vials" Labeled ''Smallpox'' Found In Philly Lab Vials of what was labeled "Smallpox" were reportedly found in a lab freezer in Philadelphia on Monday night, sparking an immediate response from the FBI and the CDC. Yahoo News reports that the 15 "questionable vials" were found in the Merck Pennsylvania lab freezer, with 10 labeled as "Vaccinia" and the remaining five labeled as deadly "Smallpox." The facility was immediately locked down. There is no indication that anyone has been exposed to the small number of frozen vials. The frozen vials labeled Smallpox were incidentally discovered by a laboratory worker while cleaning out a freezer in a facility that conducts vaccine research in Pennsylvania, a CDC spokesperson told Yahoo News. CDC, its Administration partners, and law enforcement are investigating the matter, and the vials contents appear intact. The laboratory worker who discovered the vials was wearing gloves and a face mask. We will provide further details as they are available, the spokesperson said.

Carroll Financial Associates Inc. cut its stake in Merck & Co., Inc. (NYSE:MRK) by 4.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 22,599 shares of the company’s stock after selling 1,037 shares during the quarter. Carroll Financial Associates Inc.’s holdings in Merck & Co., Inc. were worth $1,697,000 as of its most recent […]

Another exploration Titled "Worldwide Hepatitis B Therapeutics 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central

Related Stocks: IVV , IJR , VSCO , MDT , DHR , AGG , MRK ,

GENEVA: US pharmaceutical giant Pfizer on Tuesday (Wednesday in Manila) announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world''s least-wealthy countries. Pfizer will sublicense production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent (around 3.8 billion) of the world''s population. Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer which also produces one of the most widely used Covid vaccines with German lab BioNTech will not receive royalties from the generic manufacturers, making the treatment cheaper. The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval. The Pfizer drug is to be taken with the human immunodeficiency virus medicine ritonavir. Interim data from ongoing trials demonstrated an 89-percent reduction in the risk of Covid-19-related hospitalization or death compared to a placebo, in nonhospitalized high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Related Stocks: MRK , CSCO , IBM , BRK.B , UL , CNP , TFC , LMT , CMC , CNO , XEC , WRK , BA , QELL , SPNV , MKTW , RAAC , STPC ,

CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the appointment of Stephen L. Mayo, Ph.D., to its Board of Directors, effective immediately. Dr. Mayo is currently the Bren Professor of Biology and Chemistry at California Institute of Technology (Caltech), and serves on the board of directors for Merck and on the scientific advisory board of Rubryc Therapeutics.

This Poultry Health market research stud offers proper industry viewpoint, market size, growth, future trends and trading. All this are taken into consideration while preparing the market report with the forecast period from 2021 to 2027. This report contains a

Market trends, major suppliers and competitive landscape are covered in this Periodic Fever Syndrome market study along with capturing market scenario estimation for the foretell duration 2021-2027. By adopting a few key business indicators, key players aim at expanding their